Finance

Lists
G1SK34:BVMF
Gsk Plc Bdr
50,50 R$
0,00%
(0,00) 1D
16 қаз., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for G1SK34...
Open
50,10 R$
High
50,75 R$
Low
50,10 R$
Mkt. cap
100,71 млрд
Avg. vol.
214,00
Volume
165,00
52-wk high
63,24 R$
52-wk low
46,15 R$
Shares outstanding
4,32 млрд
No. of employees
67 мың
Open
50,10 R$
High
50,75 R$
Low
50,10 R$
Mkt. cap
100,71 млрд
Avg. vol.
214,00
Volume
165,00
52-wk high
63,24 R$
52-wk low
46,15 R$
Shares outstanding
4,32 млрд
No. of employees
67 мың
News stories
From web sources and news partners
Profile
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England. GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500. The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK. The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
About Gsk Plc Bdr
CEOEmma Walmsley | Emma Walmsley
Employees66,8 мың
Founded2000 ж. 27 жел.
Headquarters-
SectorPharmaceutical industry
Websitegsk.com
Next call 11 күннен кейін
28 қаз., ср, 14:00
Fiscal period
Q3 2026
- / 0,50 £
Revenue / Est. (GBP)
- / 8,81 млрд
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
8,55 млрд
8,62 млрд
7,63 млрд
8,41 млрд
Cost of goods sold
2,24 млрд
2,62 млрд
1,87 млрд
2,07 млрд
Cost of revenue
2,24 млрд
2,62 млрд
1,87 млрд
2,07 млрд
Research and development expenses
1,58 млрд
2,14 млрд
1,52 млрд
1,75 млрд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,16 млрд
2,67 млрд
2,08 млрд
2,19 млрд
Operating expense
3,23 млрд
4,37 млрд
2,99 млрд
3,74 млрд
Total operating expenses
5,46 млрд
6,99 млрд
4,86 млрд
5,81 млрд
Operating income
3,08 млрд
1,63 млрд
2,77 млрд
2,60 млрд
Other non operating income
-
-21,00 млн
-
-
EBT including unusual items
2,46 млрд
950,00 млн
2,14 млрд
354,00 млн
EBT excluding unusual items
2,94 млрд
1,48 млрд
2,62 млрд
2,48 млрд
Income tax expense
312,00 млн
223,00 млн
305,00 млн
-199,00 млн
Effective tax rate
12,70%
23,47%
14,23%
-56,21%
Other operating expenses
-511,00 млн
-434,00 млн
-615,00 млн
-204,00 млн
Net income
2,01 млрд
636,00 млн
1,74 млрд
435,00 млн
Net profit margin
23,55%
7,38%
22,77%
5,17%
Earnings per share
0,55
-
-
-
Interest and investment income
26,00 млн
17,00 млн
22,00 млн
58,00 млн
Interest expense
-167,00 млн
-145,00 млн
-167,00 млн
-182,00 млн
Net interest expenses
-141,00 млн
-128,00 млн
-145,00 млн
-124,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
3,82 млрд
2,69 млрд
3,23 млрд
2,82 млрд
Gain or loss from assets sale
-
-40,00 млн
-
-
AI content may include mistakes. Learn more
Google қолданбалары